{"name":"Butabarbital","slug":"butabarbital","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Secbutabarbital","Secbutobarbitone","Butatab","Butisol","Butabarbitone","Secbubarbital","Medarsed","Unicelles","Nilox","Butrate"],"brands":[],"scraped":true,"has_structure":true,"cid":2479,"classes":[],"families":[{"name":"barbiturate","href":"/substituted/barbiturate"}],"physical":[{"label":"Molecular mass","value":"212.25 g/mol","copyable":false},{"label":"Appearance","value":"Fine, white, microcrystalline powder","copyable":false},{"label":"Odor","value":"Odorless","copyable":false},{"label":"Taste","value":"Bitter","copyable":false},{"label":"Melting point","value":"166.5 °C","copyable":false},{"label":"Decomposition","value":"When heated to decomp it emits toxic fumes of oxides of /nitric oxide/.","copyable":false},{"label":"Solubility","value":"WHITE POWDER; PRACTICALLY INSOL IN BENZENE &amp; ABS ETHER /SODIUM SALT/","copyable":false},{"label":"Predicted LogP","value":"1.6","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>10</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub>","copyable":true},{"label":"IUPAC name","value":"5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione","copyable":true},{"label":"SMILES","value":"CCC(C)C1(C(=O)NC(=O)NC1=O)CC","copyable":true},{"label":"InChI","value":"InChI=1S/C10H16N2O3/c1-4-6(3)10(5-2)7(13)11-9(15)12-8(10)14/h6H,4-5H2,1-3H3,(H2,11,12,13,14,15)","copyable":true},{"label":"InChIKey","value":"ZRIHAIZYIMGOAB-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"125-40-6","copyable":true},{"label":"UNII","value":"P0078O25A9","copyable":true},{"label":"PubChem CID","value":"2479","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"100 hours<a href=\"#cite_note-3\"><sup>[3]</sup></a>","copyable":false},{"label":"Excretion","value":"Urine<a href=\"#cite_note-4\"><sup>[4]</sup></a>","copyable":false}],"toxicity":[],"dosing":null,"salts":[],"esters":[],"chirality":"racemic","stereo_type":"enantiomer","optical_activity":"( + / - )","stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[],"mesh":[{"name":"Hypnotics and Sedatives","id":"M0010885"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"GABRA1","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA2","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA3","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA4","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA5","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA6","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRB1","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRB2","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRB3","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRD","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRE","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRG1","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRG2","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRG3","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRP","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRQ","mechanisms":["shared target"],"partners":32,"contraindicated":0}],"mechanism":"Barbiturates like butabarbital potentiate GABA-A receptors and inhibit receptors for neuronal acetylcholine, and kainate. GABA-A receptors are predominantly on the post-synaptic membrane, and upon activation, open chloride channels to hyperpolarize the neuron and decreased firing rate. Potentiation of GABAergic neurons produces sedation. Inhibition of neuronal acetylcholine receptors and glutamate receptors of the kainate subtype desensitize their respective neurons, producing sedation.","side_effects":{"drug_id":2479,"drug_name":"butabarbital","url":"https://sideeffects.embl.de/drugs/2479/pt","atc_codes":[],"side_effects":[{"name":"Angioedema","cui":"C0002994"},{"name":"Anxiety","cui":"C0003467"},{"name":"Apnoea","cui":"C0003578"},{"name":"Ataxia","cui":"C0004134"},{"name":"Confusional state","cui":"C0009676"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Constipation","cui":"C0009806"},{"name":"Dermatitis exfoliative","cui":"C0011606"},{"name":"Dizziness","cui":"C0012833"},{"name":"Syncope","cui":"C0039070"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Body temperature increased","cui":"C0015967"},{"name":"Hallucination","cui":"C0018524"},{"name":"Headache","cui":"C0018681"},{"name":"Hypersensitivity","cui":"C0020517"},{"name":"Hypotension","cui":"C0020649"},{"name":"Nausea","cui":"C0027497"},{"name":"Nervousness","cui":"C0027769"},{"name":"Tension","cui":"C0233494"},{"name":"Nightmare","cui":"C0028084"},{"name":"Shock","cui":"C0036974"},{"name":"Loss of consciousness","cui":"C0041657"},{"name":"Vomiting","cui":"C0042963"},{"name":"Agitation","cui":"C0085631"},{"name":"Hyperkinesia","cui":"C0424295"},{"name":"Depressed level of consciousness","cui":"C0549249"},{"name":"Hepatocellular injury","cui":"C0151763"},{"name":"Liver injury","cui":"C0160390"},{"name":"Bradycardia","cui":"C0428977"},{"name":"Somnolence","cui":"C2830004"},{"name":"Hypoxia","cui":"C0242184"},{"name":"Respiratory failure","cui":"C1145670"},{"name":"Hypoventilation","cui":"C3203358"}],"indications":[{"name":"Insomnia","cui":"C0917801"}]},"effects":null,"usernotes":[{"user":"bonzi","user_slug":"bonzi","external":false,"note":{"substance":"Butabarbital","composite":false,"routes":[],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Brazil","status":"B1","act":null,"refs":[5]},{"jurisdiction":"Canada","status":"Schedule IV","act":null,"refs":[]},{"jurisdiction":"United States","status":"Schedule III","act":"Controlled Substances Act","refs":[]},{"jurisdiction":"Germany","status":"Anlage II","act":"Betäubungsmittelgesetz (BtMG)","refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Butabarbital"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/2479"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q410608"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00237"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL449"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A3228"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=125-40-6"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0014382"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07827"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID2022709"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Butabarbital"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/P0078O25A9"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/2479/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 2479, Butabarbital. Accessed November 22, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/2479>https://pubchem.ncbi.nlm.nih.gov/compound/2479</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Butabarbital. UNII: P0078O25A9. Global Substance Registration System. Accessed November 22, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/P0078O25A9>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/P0078O25A9</a>","Butisol. RxList. <a href='http://www.rxlist.com/butisol-drug.html'>http://www.rxlist.com/butisol-drug.html</a>","Maynert EW, Losin L. The metabolism of butabarbital (butisol) in the dog. The Journal of Pharmacology and Experimental Therapeutics. November 1955; 115(3):275–82. PMID 13272177.","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 18:01:50","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 18:01:45","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 18:01:46","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 18:01:46","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 18:01:46","note":"hmdb.ca refused automated access to HMDB0014382"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 18:01:48","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 18:01:44","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 18:01:45","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 18:01:46","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 18:01:45","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 18:01:46","note":null}],"description":"Butabarbital is a  substance."}